# Paige.Ai, Inc.

- Location (FDA's records): New York, NY
- FDA decisions: 3 (2020–2025): 2 510(k) clearances and 1 De Novo grant
- Names in FDA's records: Paige.Ai, Inc. (2); Paige.Ai (1)
- Product codes: QKQ (2), QPN (1)
- Predicates its devices cite: 3 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Leica Biosystems Imaging, Inc.: 1 (https://510kreport.com/company/leica-biosystems-imaging)
- Hamamatsu Photonics K.K.: 1 (https://510kreport.com/company/hamamatsu-photonics)
- Philips Medical Systems Nederland B.V.: 1 (https://510kreport.com/company/philips-medical-systems-nederland)

## Firms that cite its devices most
- Ibex Medical Analytics, Ltd.: 1 (https://510kreport.com/company/ibex-medical-analytics)

## Its most-cited devices
- DEN200080: Paige Prostate (2021), cited by 1

## Recent decisions
- K241273: FullFocus (Jan 9, 2025)
- DEN200080: Paige Prostate (Sep 21, 2021)
- K201005: FullFocus (Jul 15, 2020)

Source page: https://510kreport.com/company/paige-ai